»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Ư¼ö ÀǾàǰ ½ÃÀåÀº 2024-2029³â¿¡ 5,031¾ï ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø±â°£ Áß CAGRÀº 14.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Ư¼ö ÀǾàǰ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. Á¤ºÎÀÇ ÇコÄɾî ÁöÃâ·Î ÀÎÇÑ ¿¬±¸°³¹ß ¼ö¿ä Áõ°¡, Ư¼ö ÀǾàǰ ¿¬±¸°³¹ßºñ¿ë Àý°¨ÀÇ Çʿ伺, º¹ÀâÇÑ Áúº´°ú ±× ¿¹¹æ¿¡ ´ëÇÑ ÀνÄÀ» È®»êÇϱâ À§ÇÑ Á¤ºÎ ¹× ´Ù¾çÇÑ ºñ¿µ¸® ´ÜüÀÇ ³ë·Â µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ¿¬µµ
2025
Á¾·á¿¬µµ
2029
¿¹Ãø ±â°£
2025-2029
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ
12.5%
CAGR
14.8%
Áõ°¡¾×
5,031¾ï ´Þ·¯
º» Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü¿©ÀÚµéÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î Á¶ÇÕÇÏ¿© ½Ç½ÃµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®°ú ÇÔ²² Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ª ºÐ¼®¿¡ µû¸¥ ¼¼ºÐÈ, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
º» Á¶»ç¿¡¼´Â ÇâÈÄ ¼ö³â°£ Àü¹®ÀǾàǰ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ³ëÀÎ Àα¸ Áõ°¡¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ Á¦Á¶¾÷üÀÇ Àü¹®ÀǾàǰ¿¡ ´ëÇÑ ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡, ¹ÙÀÌ¿ÀÀǾàǰ »ê¾÷¿¡ ´ëÇÑ ÅõÀÚ ¹× °³¹ß Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå Technavio ºÐ¼®
°¡°Ý¡¤¼ö¸íÁֱ⡤°í°´ ±¸ÀÔ ¹Ù½ºÄÏ¡¤Ã¤Å÷ü¡¤±¸ÀÔ ±âÁØÀÇ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°ÈÀÇ ¿äÀÎ
È¥¶õÀÇ ¿äÀÎ
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå ¿¡ÄڽýºÅÛ
½ÃÀåÀÇ Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2024
½ÃÀå Àü¸Á 2024-2029
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ Æ¯¼ö ÀǾàǰ ½ÃÀå 2019-2023
¿ëµµº° ºÎ¹® ºÐ¼® 2019-2023
À¯Åë ä³Îº° ºÎ¹® ºÐ¼® 2019-2023
Åõ¿© °æ·Îº° ºÎ¹® ºÐ¼® 2019-2023
Áö¿ªº° ºÎ¹® ºÐ¼® 2019-2023
±¹°¡º° ºÎ¹® ºÐ¼® 2019-2023
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ¼¼°èÀÇ Æ¯¼ö ÀǾàǰ ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : ¿ëµµº°
½ÃÀå ºÎ¹®
ºñ±³ : ¿ëµµº°
Á¾¾çÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
´Ù¹ß¼º °æÈÁõ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¿°Áõ¼º Áúȯ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
°¨¿°Áõ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ÃÀå ±âȸ : ¿ëµµº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : À¯Åë ä³Îº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Åë ä³Îº°
¿ÀÇÁ¶óÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¿Â¶óÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ÃÀå ±âȸ : À¯Åë ä³Îº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : Åõ¿© °æ·Îº°
½ÃÀå ºÎ¹®
ºñ±³ : Åõ¿© °æ·Îº°
ÈíÀÔ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ÁÖ»çÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
°æ±¸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¿Ü¿ë : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
°æÇÇ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ÃÀå ±âȸ : Åõ¿© °æ·Îº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¼¼°èÀÇ ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ºÆäÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀåÀÇ ±âȸ¡¤¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°èÀÇ ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
AbbVie Inc.
Amgen Inc.
Bristol Myers Squibb Co.
F. Hoffmann La Roche Ltd.
Gilead Sciences Inc.
Johnson and Johnson Services Inc.
McKesson Corp.
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi SA
Supernus Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
The Cigna Group
Viatris Inc.
Á¦16Àå ºÎ·Ï
KSA
The specialty pharmaceuticals market is forecasted to grow by USD 503.1 bn during 2024-2029, accelerating at a CAGR of 14.8% during the forecast period. The report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for research and development due to government healthcare expenditure, need for cost-cutting in specialty pharmaceutical discovery and development, and initiatives by government and various non-profit organizations to spread awareness of complex diseases and their prevention.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 12.5%
CAGR 14.8%
Incremental Value $503.1 bn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's specialty pharmaceuticals market is segmented as below:
By Application
Oncology
Multiple sclerosis
Inflammatory conditions
Infectious diseases
Others
By Distribution Channel
By Route Of Administration
Inhalation
Injectable
Oral
Topical
Transdermal
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the increasing geriatric population as one of the prime reasons driving the specialty pharmaceuticals market growth during the next few years. Also, increase in research and development investments in specialty pharmaceuticals by manufacturers and rising investments and developments in biopharmaceutical industry will lead to sizable demand in the market.
The report on the specialty pharmaceuticals market covers the following areas:
Specialty Pharmaceuticals Market sizing
Specialty Pharmaceuticals Market forecast
Specialty Pharmaceuticals Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading specialty pharmaceuticals market vendors that include AbbVie Inc., Amgen Inc., Bristol Myers Squibb Co., CVS Health Corp., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Humana Inc., Hyphens Pharma Pte Ltd., Johnson and Johnson Services Inc., McKesson Corp., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., The Cigna Group, United Health Group Inc., and Viatris Inc.. Also, the specialty pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ billion)
Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Specialty Pharmaceuticals Market 2019 - 2023
Historic Market Size - Data Table on Global Specialty Pharmaceuticals Market 2019 - 2023 ($ billion)
5.2 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ billion)
5.3 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
5.4 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI in the global specialty pharmaceuticals market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
8.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ billion)
Data Table on Oncology - Market size and forecast 2024-2029 ($ billion)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
8.4 Multiple sclerosis - Market size and forecast 2024-2029
Chart on Multiple sclerosis - Market size and forecast 2024-2029 ($ billion)
Data Table on Multiple sclerosis - Market size and forecast 2024-2029 ($ billion)
Chart on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
Data Table on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
8.5 Inflammatory conditions - Market size and forecast 2024-2029
Chart on Inflammatory conditions - Market size and forecast 2024-2029 ($ billion)
Data Table on Inflammatory conditions - Market size and forecast 2024-2029 ($ billion)
Chart on Inflammatory conditions - Year-over-year growth 2024-2029 (%)
Data Table on Inflammatory conditions - Year-over-year growth 2024-2029 (%)
8.6 Infectious diseases - Market size and forecast 2024-2029
Chart on Infectious diseases - Market size and forecast 2024-2029 ($ billion)
Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ billion)
Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ billion)
Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)
9 Market Segmentation by Distribution Channel
9.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
9.3 Offline - Market size and forecast 2024-2029
Chart on Offline - Market size and forecast 2024-2029 ($ billion)
Data Table on Offline - Market size and forecast 2024-2029 ($ billion)
Chart on Offline - Year-over-year growth 2024-2029 (%)
Data Table on Offline - Year-over-year growth 2024-2029 (%)
9.4 Online - Market size and forecast 2024-2029
Chart on Online - Market size and forecast 2024-2029 ($ billion)
Data Table on Online - Market size and forecast 2024-2029 ($ billion)
Chart on Online - Year-over-year growth 2024-2029 (%)
Data Table on Online - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ billion)
Data Table on Market opportunity by Distribution Channel ($ billion)
10 Market Segmentation by Route of Administration
10.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
10.3 Inhalation - Market size and forecast 2024-2029
Chart on Inhalation - Market size and forecast 2024-2029 ($ billion)
Data Table on Inhalation - Market size and forecast 2024-2029 ($ billion)
Chart on Inhalation - Year-over-year growth 2024-2029 (%)
Data Table on Inhalation - Year-over-year growth 2024-2029 (%)
10.4 Injectable - Market size and forecast 2024-2029
Chart on Injectable - Market size and forecast 2024-2029 ($ billion)
Data Table on Injectable - Market size and forecast 2024-2029 ($ billion)
Chart on Injectable - Year-over-year growth 2024-2029 (%)
Data Table on Injectable - Year-over-year growth 2024-2029 (%)
10.5 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ billion)
Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.6 Topical - Market size and forecast 2024-2029
Chart on Topical - Market size and forecast 2024-2029 ($ billion)
Data Table on Topical - Market size and forecast 2024-2029 ($ billion)
Chart on Topical - Year-over-year growth 2024-2029 (%)
Data Table on Topical - Year-over-year growth 2024-2029 (%)
10.7 Transdermal - Market size and forecast 2024-2029
Chart on Transdermal - Market size and forecast 2024-2029 ($ billion)
Data Table on Transdermal - Market size and forecast 2024-2029 ($ billion)
Chart on Transdermal - Year-over-year growth 2024-2029 (%)
Data Table on Transdermal - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ billion)
Data Table on Market opportunity by Route of Administration ($ billion)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ billion)
Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ billion)
Data Table on US - Market size and forecast 2024-2029 ($ billion)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ billion)
Data Table on China - Market size and forecast 2024-2029 ($ billion)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ billion)
Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ billion)
Data Table on France - Market size and forecast 2024-2029 ($ billion)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ billion)
Data Table on India - Market size and forecast 2024-2029 ($ billion)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ billion)
Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
15.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
15.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
15.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.8 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
SWOT
15.9 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
15.10 McKesson Corp.
McKesson Corp. - Overview
McKesson Corp. - Business segments
McKesson Corp. - Key news
McKesson Corp. - Key offerings
McKesson Corp. - Segment focus
SWOT
15.11 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.13 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.14 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.15 Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc. - Overview
Supernus Pharmaceuticals Inc. - Product / Service
Supernus Pharmaceuticals Inc. - Key offerings
SWOT
15.16 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
15.17 The Cigna Group
The Cigna Group - Overview
The Cigna Group - Product / Service
The Cigna Group - Key offerings
SWOT
15.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations